Leaderboard
Anzeige
Fr
|
De
Feedback
|
Impressum
|
Sitemap
Aucun choix d'articles!
Panier
Vous êtes ici:
Recherche de documentation spécialisée
»
Œsophage
»
Néoplasie
23. Juin 2026
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Estomac / intestins
Œsophage
Troubles de la motilité
Néoplasie
Autres
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
Anzeige
Écriture:
Page 1 de 1953
Articles 1 - 20 / 39056
Association of SIRT1 rs12778366 (T > C) polymorphism with reduced esophageal cancer risk: a case-control study from North India".
Mol Biol Rep
Bali JS, Sambyal V, Mehrotra S, Guleria K, Uppal MS, Manjari M, Sudan M.
PMID: 42334702 [PubMed - in process]
Factors associated with self-care engagement among oesophageal and gastric cancer survivors: a population-based cross-sectional study.
Qual Life Res
Färnqvist K, Färnqvist S, Johar A, Schandl A, Lagergren P.
PMID: 42334670 [PubMed - in process]
Circulating tumour DNA in oligometastatic oesophago-gastric cancers: applications, challenges, and future directions.
Dis Esophagus
Cammarota A, Puccini A, Jones CM, van Rossum PSN, Mouliere F, van Laarhoven HWM.
PMID: 42330311 [PubMed - indexed for MEDLINE]
Quality, Reliability, and Viewer Engagement of YouTube Videos on Esophageal Cancer: A Cross-Sectional Study.
Ann Surg Oncol
Carkit S, Karaagac M.
PMID: 42329563 [PubMed - as supplied by publisher]
Heterogeneity of adjuvant therapy effectiveness across post-neoadjuvant pathologic strata in esophageal squamous cell carcinoma: a retrospective cohort study.
Esophagus
Ge Q, Feng X, Guo C, Lu T, Lian J, Li J.
PMID: 42329554 [PubMed - as supplied by publisher]
Evaluating pegenzileukin (SAR444245/THOR-707) in combination with pembrolizumab or cetuximab in advanced metastatic gastrointestinal cancer: the PEGATHOR phase 2 study.
Invest New Drugs
Harris WP, García-Alfonso P, Metges JP, Cubillo-Gracian A, Zaanan A, Carlos LL, Ronzoni M, Ponz-Sarvise M, Baakili A, Kefsi A, Andrieu L, Agrawal M, Wang W, Paehler T, Abbadessa G, Van Cutsem E.
PMID: 42329347 [PubMed - as supplied by publisher]
Esophageal Small Cell Carcinoma: From Bench Discoveries to Bedside Therapeutics.
Int J Biol Sci
Wang Z, Zhang J, Ji C, Yu J, Shen B, Meng X, Shan Z, Guan L, Yue B, Xin D, Zhao T, Wang F.
PMID: 42328440 [PubMed - indexed for MEDLINE]
Prognostic value of tertiary lymphoid structures in locally advanced esophageal squamous cell carcinoma treated with neoadjuvant chemoimmunotherapy: a retrospective study.
J Cardiothorac Surg
Xue T, Wu Y, Zi Q, Zi T, Gao S, Mao J, Peng Y, Chen J, Wang X.
PMID: 42324542 [PubMed - as supplied by publisher]
Adjuvant Immunotherapy Improves Esophageal Squamous Cell Carcinoma Survival After Neoadjuvant Chemoimmunotherapy: A Multicenter Real-World Study.
Ann Surg Oncol
Xie Z, Xiu Z, Lin Y, Gong N, Peng F, Zhang W, Wang R, Wang W.
PMID: 42323452 [PubMed - as supplied by publisher]
Cancer burden and control in China: landscape, trends and challenges.
Nat Rev Clin Oncol
Xia C, Li H, Wu C, Chen W.
PMID: 42321391 [PubMed - as supplied by publisher]
STS Expert Consensus Document (2026) on Addressing Definition and Practices of Sublobar Resection in Non-small Cell Lung Cancer.
Ann Thorac Surg
Khullar OV, Kidane B, Altorki N, Antonoff M, Axtell AL, Kim SS, Krantz SB, Mitzman B, Raymond DP, Seder CW, Sood P, Towe CW, Wakwe WC, Crabtree T, Hayanga JWA.
PMID: 42320552 [PubMed - as supplied by publisher]
Immunotherapy-based adjuvant treatment after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma according to pathological response.
Front Immunol
Wang C, Geng X, Cheng X, Ren R, Jin L, Sheng Z, Li S, Zang M, Zhang Y.
PMID: 42317368 [PubMed - indexed for MEDLINE]
Overcoming chemoresistance in esophageal cancer with synergistic strategies.
Front Immunol
Gao C, Zhang T, Li G, Zhang W, Chen H, Li D, Xu J, Li M, Wang R, Xing Y, Zhan J, Ren Z, Xue X, Liang W, Sun X, Zhang X, Liang X, Zhan H, Zhang Z, Chu X.
PMID: 42317336 [PubMed - indexed for MEDLINE]
A Randomized Controlled Phase 3 Trial of Oral Prednisolone Administration Versus Local Triamcinolone Injection Therapy for Esophageal Stricture Prevention After Extensive Endoscopic Submucosal Dissection (JCOG1217).
Dig Endosc
Tanaka M, Ono H, Takizawa K, Iwamoto S, Sano Y, Abe S, Kadota T, Wada T, Ishiyama A, Nakanishi H, Nagata S, Fukuda H, Muto M, Yano T, Gastrointestinal Endoscopy Study Group of the Japan Clinical Oncology Group.
PMID: 42313516 [PubMed - indexed for MEDLINE]
Smoking, Tumor Subsite, and Stage as Predictors of Second Primary Tumors in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Retrospective Cohort Study.
Head Neck
da Silva FMA, Mortari GR, Buexm LA, Carvalho RS, Hirai WY, de Oliveira C, Ferigatto JL, de Lima Vazquez F, Coracin FL, de Matos LL, Gama RR.
PMID: 42311007 [PubMed - as supplied by publisher]
ASO Visual Abstract: Impact of Muscle Mass Loss on Survival During Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Multi-Center Retrospective Study in China (TIMES Study).
Ann Surg Oncol
Huang G, Zhu J, He B, Zhang W, Huang W, Tang X, Zhang L, Wang Q.
PMID: 42310270 [PubMed - as supplied by publisher]
Treatment completion rate, toxicity, and 90-Day unplanned readmission in older adults with esophageal squamous cell carcinoma receiving radiotherapy alone versus concurrent chemoradiotherapy.
J Gerontol A Biol Sci Med Sci
Xie J, Zhang L, Yuan Y, Yan X, Wang Y, Li S, Yu X.
PMID: 42308557 [PubMed - indexed for MEDLINE]
Development and validation of a collagen score-based prediction model for neoadjuvant chemoimmunotherapy efficacy in locally advanced esophageal squamous cell carcinoma.
J Thorac Dis
Chen XF, Zhang HY, Chen WJ, Lin JP, Zhou H, Chen YJ, Gao PQ, Wang F.
PMID: 42306753 [PubMed]
Development and internal validation of a prognostic model for esophageal cancer liver metastases using the Surveillance, Epidemiology, and End Results database.
J Thorac Dis
Jiang J, Zeng Y, Wan J, Zhang L, Zhang Z, Bai R, Wang C, Lin F.
PMID: 42306725 [PubMed]
Machine learning to predict distant metastasis risk and prognostic analysis in T1-2 esophageal cancer: a study based on the SEER database.
J Thorac Dis
Shi P, Yang P, Wu H, Lian C, Zhu B, Li Y.
PMID: 42306722 [PubMed]
Articles 1 - 20 / 39056
Page 1 de 1953
Rect Bottom
Anzeige
Adserver Footer
Intervalle de temps demandé
--sans limitation--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy
|
Publicité